Del Carmen Jeffrey 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Del Carmen Jeffrey
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2025-02-14+10,667→ 33,548 total - Tax Payment
Common stock, par value $0.001 per share
2025-02-14−3,125→ 30,423 total - Exercise/Conversion
Restricted Stock Units
2025-02-14−10,667→ 931,008 total→ Common Stock (10,667 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
- [F3]Derivative securities vested in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on February 14, 2025.